首页 | 本学科首页   官方微博 | 高级检索  
     

快速灵敏的LC-MS/MS法测定人血浆中缬沙坦浓度
引用本文:李玲,谭志荣,陈尧,周淦,郭栋,严谨,阳国平,欧阳冬生. 快速灵敏的LC-MS/MS法测定人血浆中缬沙坦浓度[J]. 中国临床药理学与治疗学, 2010, 15(7): 809-813
作者姓名:李玲  谭志荣  陈尧  周淦  郭栋  严谨  阳国平  欧阳冬生
作者单位:1. 中南大学临床药理研究所,长沙,410078,湖南;中南大学药学院,长沙,410078,湖南
2. 中南大学临床药理研究所,长沙,410078,湖南
3. 中南大学湘雅三医院,长沙,410013,湖南
摘    要:目的:建立一种快速、灵敏的高效液相色谱-串联质谱法(LC-MS/MS)测定人血浆缬沙坦浓度。方法:200μL血浆样品经乙腈一步沉淀蛋白后,在Inertsil ODS-色谱柱(2.1mm×150mm,5μm)上分离,流动相由乙腈和1‰甲酸水溶液(70∶30)组成。采用电喷雾离子源(ESI源)正离子多反应监测(MRM)扫描分析,缬沙坦和厄贝沙坦的离子选择通道分别为:m/z436.3→235.2和429.4→207.2。结果:缬沙坦的线性范围为24.2~3100.0μg/L,日内和日间相对标准差均小于15%。结论:本法操作快速、灵敏,适用于缬沙坦的临床药动学研究。

关 键 词:缬沙坦  液质联用法  生物等效性

A rapid and sensitive LC-MS/MS method for determination of valsartan in human plasma
LI Ling,TAN Zhi-rong,CHEN Yao,ZHOU Gan,GUO Dong,YAN Jin,YANG Guo-ping,OUYANG Dong-sheng. A rapid and sensitive LC-MS/MS method for determination of valsartan in human plasma[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(7): 809-813
Authors:LI Ling  TAN Zhi-rong  CHEN Yao  ZHOU Gan  GUO Dong  YAN Jin  YANG Guo-ping  OUYANG Dong-sheng
Affiliation:LI Ling1,2, TAN Zhi-rong1, CHEN Yao1, ZHOU Gan1, GUO Dong1, YAN Jin1, YANG Guo-ping3, OUYANG Dong-sheng11Institute of Clinic Pharmacology, Central South University, Changsha 410078,Hunan, China;2School of Pharmaceutics, Central South University, Changsha 410078, Hunan,China; 3The Third Xiangya Hospital, Central South University, Changsha 410013, Hunan,China
Abstract:AIM:To establish a rapid and sensitive LC-MS/MS method for determination of valsartan in human plasma. METHODS: The prepared analytes were separated on an ODS column using mobile phase of acetonitrile and 1‰ methanoic acid (70∶30). Valsartan and irbesartan were detected by multiple reaction monitoring (MRM) mode after ionized by ESI source. The transitions of m/z436.3→235.2 and m/z 429.4→207.2 were used to quantify valsartan and irbesartan, respectively. RESULTS:The method was linear in the range of 24.2-3100.0 μg/L for valsartan. The intra-day mean precision and inter-day mean accuracy precision was not more than 15%. CONCLUSION: The method is rapid and sensitive, and it's adaptive for clinic pharmacokinetic evaluation of valsartan.
Keywords:Valsartan  LC-MS/MS  Bioequivalence
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号